US2005222217A1PendingUtilityA1
Non-systemic control of parasites
Est. expiryMay 20, 2014(expired)· nominal 20-yr term from priority
A01N 61/00A61P 43/00A61P 33/00A01N 51/00A61P 33/14A01N 43/40A01N 43/78
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
10 . A method for non-systemically controlling a parasitic insect selected from fleas and lice on a human or animal, said method comprising contacting said parasitic insect with an effective amount therefor of a compound of the formula:
wherein
n represents 1 or 2;
Subst. represents halogen;
A represents hydrogen or alkyl having 1 to 4 carbon atoms; and
Z represents optionally substituted alkyl;
E represents NO 2 or CN; and
X represents —CH═ or —N═;
wherein said contacting of said parasitic insect with said compound is effected by:
a) topically applying said compound to the dermis of said human or animal; or
b) contacting the dermis of said human or animal with an article containing said compound;
and wherein said contacting of said parasitic insect with said compound does not result in said compound being systemically distributed within said human or animal.
11 . The method according to claim 10 , which comprises contacting said parasitic insect with the compound:
12 . The method according to claim 10 , wherein the animal is a dog or cat infested with fleas.
13 . The method according to claim 12 , wherein said contacting is effected by applying said compound topically to the dermis of said dog or cat by a pour-on or spot-on method.
14 . The method according to claim 12 , wherein said contacting is effected by contacting the dermis of said dog or cat with an article containing said compound.
15 . The method according to claim 10 , which is carried out on a human, and the human is infected with lice.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.